Erwan Le Rouzic-Muros
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 23, 2024
Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments.
Journal: Journal of central nervous system disease
Published: December 05, 2023
Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records.
Journal: Frontiers in neurology
Published: July 05, 2023
The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: February 06, 2023
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 20, 2022
Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Journal: Multiple sclerosis and related disorders
Published: June 01, 2022
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study.
Journal: Frontiers in neurology
Published: January 26, 2022
Adolescents and adults with Fontan circulation: insights from the PREpArE-Fontan registry.
Journal: Cardiology in the young
Published: July 23, 2021
Understanding the impacts of COVID-19 pandemic in people with multiple sclerosis treated with ocrelizumab.
Journal: Multiple sclerosis and related disorders
Published: July 09, 2021
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
Journal: European journal of neurology
Published: December 03, 2020
Five-Year outcomes of patients enrolled in the REVEAL Registry.
Journal: Chest
Published: June 13, 2015
Last Updated: 09/26/2026